A detailed history of Ubs Oconnor LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Ubs Oconnor LLC holds 15,000 shares of MRNA stock, worth $552,750. This represents 0.07% of its overall portfolio holdings.

Number of Shares
15,000
Holding current value
$552,750
% of portfolio
0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

BUY
$221.9 - $484.47 $332,850 - $726,705
1,500 Added 25.0%
7,500 $2.89 Million
Q2 2021

Aug 13, 2021

BUY
$129.91 - $234.98 $779,460 - $1.41 Million
6,000 New
6,000 $1.41 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Ubs Oconnor LLC Portfolio

Follow Ubs Oconnor LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.